This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background Atrialfibrillation (AF) and acute myocardialinfarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both conditions. Whether the risks of outcomes differ according to temporal order of AF and AMI is unclear.
Radiofrequency ablation (RFA) is an important therapeutic modality for atrialfibrillation (AF), widely utilized in clinical practice due to its safety and significant efficacy. This case report describes a unique instance of a patient developing AEF following AF ablation, accompanied by ischemic stroke and myocardialinfarction.
atrialfibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the heart, affects up to one in three people in their lifetime. Significant complications associated with this condition include ischemic stroke, heart failure, myocardialinfarction, chronic kidney disease, dementia and mortality.
Specific cardiovascular diseases, such as acute myocardialinfarction, arrhythmias, pulmonary hypertension and pericarditis, were also pointed. SiO2 exposure was linked to an increased risk of myocardialinfarction, with potential mechanisms involving inflammation and platelet activation.
Primary adverse events were defined as myocardialinfarction, thromboembolism, transient ischemic attack, diaphragmatic paralysis, pneumothorax, heart block, pulmonary edema, vagal nerve injury, pericarditis, major vascular access complication or bleeding, death, stroke, or any other cerebrovascular accident. Int J Stroke.
Previous observational studies have documented an inverse association of birthweight with myocardialinfarction (MI) but a positive association with atrialfibrillation (AF). However, the causality of these as.
Mediation analyses were performed to assess the proportion mediated by MDD. Results Genetically predicted insomnia, short sleep, daytime napping and daytime sleepiness increased the risk of CVDs, with the OR ranging from 1.24 (95% CI 1.06 to 1.45) for insomnia on stroke to 1.55 (95% CI 1.28 to 1.89) for insomnia on MI.
BackgroundThe effectiveness of statin use in preventing adverse cardiovascular events in individuals with atrialfibrillation (AF) has remained uncertain. Journal of the American Heart Association, Volume 13, Issue 24 , December 17, 2024.
Genetic research into atrialfibrillation (AF) and myocardialinfarction (MI) has predominantly focused on comparing afflicted individuals with their healthy counterparts. However, this approach lacks granularity, thus overlooking subtleties within patient populations.
The authors reported that the regular use of fish oil supplements might be a risk factor for atrialfibrillation among general population. In their study healthy stage was considered as primary stage, occurrence of atrialfibrillation as secondary stage, major adverse cardiovascular events tertiary stage and death as end stage.
Higher risk of myocardialinfarction, heart failure and atrialfibrillation was noted in spinal cord injury survivors compared to controls. Increased Risk of MyocardialInfarction, Heart Failure, and AtrialFibrillation After Spinal Cord Injury. Am J Phys Med Rehabil. 2007 Feb;86(2):142-52.
million Americans have atrialfibrillation. Atrialfibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.
Objective Atrialfibrillation (AF) remains a highly prevalent arrhythmia with significant burden on morbidity and mortality. The primary outcome of interest was 1-year major adverse cardiac events (MACE) defined as a composite of death, myocardialinfarction, unplanned revascularisation and cerebrovascular accidents.
Methods We retrospectively assessed whether compliance to the ‘1–3–6–12 days rule’ was associated with the composite endpoint (recurrent stroke, systemic embolism, myocardialinfarction, major bleeding or all-cause death).
Atrialfibrillation (AF) poses a major risk for heart failure, myocardialinfarction, and stroke. Several studies have linked SCN5A variants to AF, but their precise mechanistic contribution remains unclear.
BackgroundIn Thailand, access to specific pharmaceuticals and medical devices for ST-elevation myocardialinfarction (STEMI) patients is restricted within certain healthcare systems, leading to inequalities in the quality of medical care among different healthcare systems.
Atrialfibrillation (AF) is frequently under-detected but linked to cardiovascular comorbidities, including stroke. Preexisting screening modalities are known to have low performance.
The ENGAGE AF-TIMI 48 trial sought to study the safety and efficacy of edoxaban, an oral direct factor Xa inhibitor, as compared with warfarin in the treatment of atrialfibrillation.
Objective Risk-guided atrialfibrillation (AF) screening may be an opportunity to prevent adverse events in addition to stroke. The risk of AF was estimated using the FIND-AF (Future Innovations in Novel Detection of AtrialFibrillation) risk score. to 8.34; 4.27), myocardialinfarction (69.6; 12.54, 12.08
The patient presented to an outside hospital An 80yo female per triage “patient presents with chest pain, also hurts to breathe” PMH: CAD, s/p stent placement, CHF, atrialfibrillation, pacemaker (placed 1 month earlier), LBBB. Smith: This is an enormous myocardialinfarction. Next trop in AM. Peak trop 257.97
BackgroundAs the population ages, atrialfibrillation (AF) prevalence increases, but data on optimal oral anticoagulation (OAC) in patients 80 years remain limited. Journal of the American Heart Association, Ahead of Print. of AF cases. of AF cases. Anticoagulation rates were slightly lower in patients 80 years (67.9% versus 70.5%,P=0.0070).
Background:Patients with atrialfibrillation were excluded from clinical trials evaluating carotid artery stent(CAS) or carotid endarterectomy (CEA).We We divided patients based on presence or absence of atrialfibrillation. Stroke, Volume 56, Issue Suppl_1 , Page ADP39-ADP39, February 1, 2025. versus 18.8%
Ioannis Katsoularis, image courtesy of Klas Sjöberg milla1cf Thu, 12/14/2023 - 09:23 December 14, 2023 — Individuals infected with COVID-19 are also at an increased risk of suffering from heart rhythm disturbances, such as atrialfibrillation.
Myocardialinfarction (MI) with non-obstructive coronary arteries (MINOCA) covers an expanding group of patients over recent years. The very young group also had lower rates of CRF, previous MI and atrialfibrillation. Previous studies showed considerable risks of outcomes in this group.
ABSTRACT Background The epidemiological landscape and treatment efficacy of atrialfibrillation (AF) in the Middle East, notably in the United Arab Emirates (UAE), remain under-explored, presenting a distinct demographic and clinical pattern compared to Western populations. for myocardialinfarction.
This study focuses on the correlation between FAI and the morbidity of new-onset atrialfibrillation (NOAF) in MINOCA patients.Methods:This study was a single-center, observational clinical cohort study. The pericoronary fat attenuation index (FAI) could reflect the local coronary inflammation as a novel imaging marker.
Patients with atrialfibrillation (AF) taking antithrombotic (AT) therapy are at increased risk of gastrointestinal bleeding (GIB). Patients in the combination AP +AC therapy group had a higher prevalence of CAD, myocardialinfarction, and coronary/vascular stent placement compared to the AC monotherapy group.
Post-AFib myocardialinfarction was the third most common at 12%, with MI rates falling from 13.7% Heart failure was the most frequent post-AFib complication with a 41.2% lifetime risk, which remained stable at 42.9% Stroke was the second most common post-AFib complication with a 21% lifetime risk, falling from 22.4%
Publication date: 15 January 2024 Source: The American Journal of Cardiology, Volume 211 Author(s): Elin Karlsson, Tuomas Kiviniemi, Olli Halminen, Ossi Lehtonen, Konsta Teppo, Jari Haukka, Pirjo Mustonen, Jukka Putaala, Miika Linna, Juha Hartikainen, K.E. Juhani Airaksinen, Mika Lehto, FinACAF Study Group
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 AtrialFibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
BACKGROUND:Clonal hematopoiesis of indeterminate potential (CHIP), a common age-associated phenomenon, associates with increased risk of both hematological malignancy and cardiovascular disease.
This study describes the changes in cognitive function associated with coronary artery disease, myocardialinfarction, heart failure, atrialfibrillation and heart valve disease. An updated understanding of the two known pathogenic mechanisms of cardiogenic dementia is presented and discussed.
BackgroundEpistaxis is common with antithrombotic therapy and is often troublesome to patients, yet its frequency, severity, and outcomes are poorly characterized.Methods and ResultsEffective Anticoagulation with Factor Xa Next Generation in Atrial FibrillationThrombolysis in MyocardialInfarction 48 (ENGAGE AFTIMI 48) randomized 21 105 patients with (..)
We identified the subset of variables most predictive of post‐HSCT cardiovascular events, defined as a composite of cardiovascular death, myocardialinfarction, heart failure, stroke, atrialfibrillation or flutter, and sustained ventricular tachycardia.
1.06), P=0.14) and myocardialinfarction (OR, 1.07(95%CI: Pooled analysis of primary and secondary endpoints showed that DOAC significantly reduced the risk of stroke or systemic embolism by 18% (OR, 0.82(95%CI: 0.91), P<0.01), stroke by 19% (OR, 0.81(95%CI: 0.97), P=0.02), and hemorrhagic stroke by 57% (OR, 0.43(95%CI:
Background:Novel oral anticoagulants (NOACs) are currently recommended for the secondary prevention of stroke in patients with acute ischemic stroke (AIS) accompanied by atrialfibrillation (AF). The primary outcome was a composite of recurrent stroke, myocardialinfarction, and all-cause mortality.
million Americans have atrialfibrillation. Atrialfibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.
1.53), P=0.88), myocardialinfarction (OR, 0.97(95%CI: Pooled analysis of primary and secondary endpoints showed that apixaban significantly reduced the risk of stroke or systemic embolism by 47% (OR, 0.53(95%CI: 0.75), P<0.001), stroke by 44% (OR, 0.56(95%CI: 0.70), P<0.001), and ischemic stroke by 51% (OR, 0.49(95%CI:
13, A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk of stroke, atrialfibrillation and heart failure, while current pipe use was associated with increased risk of heart failure. tim.hodson Tue, 01/14/2025 - 10:11 Jan.
He then explores the apparent increased risk of myocardialinfarction, heart failure and atrialfibrillation after spinal cord injury. Eagle covers opportunities in the postpartum period to reduce cardiovascular disease risk after adverse pregnancy outcomes.
Arrhythmias, and in particular atrialfibrillation (AF), are one of the greatest healthcare challenges of our time. Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardialinfarction.
Background:Device-detected atrialfibrillation (AF) (also known as subclinical AF or atrial high-rate episodes) is a common finding in patients with an implanted cardiac rhythm device and is associated with an increased risk of ischemic stroke. Circulation, Ahead of Print. 1.00, I2=0%; moderate-quality evidence).
The mortality rate of AF during pregnancy was positively associated with an increasing CHA2DS2-VASc score (Ptrend< 0001), which was 0.35% (95% CI: 0.24%-0.47%) in the low-risk group, 1.30% (95% CI: 0.98%-1.62%) in the moderate-risk group, and 2.18% (95% CI: 0.86%-3.51%) in the high-risk group.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content